TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 16, No. 8 April 15, 2010
(The next issue will be on May 3, 2010)
__________________________________________________________
TRIGGER is also available by RSS Feed:
http://feeds.feedburner.com/blogspot/glro
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PAPERS IN PRESS
None submitted for this issue.
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1dMUJyKbxrSc0llrbA9u8qd/
Bernardi F, Dolce A, Pinotti M, Napolitano M, and Mariani G (2010) Coagulation and clinical features associated with the Arg304gln mutation (Factor VII Padua) in the Irf7 study group response to letter to the editor regarding "Factor VII deficiency (Semin Thromb Hemost 2009;35(4):400-406)". Semin Thromb Hemost 36:125-127.
http://www.ncbi.nlm.nih.gov/pubmed/20391304
Bertram JP, Williams CA, Robinson R, Segal SS, Flynn NT, and Lavik EB (2009) Intravenous hemostat: Nanotechnology to halt bleeding. Sci Transl Med 1:11ra22
http://www.ncbi.nlm.nih.gov/pubmed/20371456
Cozzi P, Chiumello D, Tubiolo D, Sicignano A, Brandi G, Bianchi P, Coppola S, Caspani ML, and Rossi G (2010) Total hepatectomy, recombinant activated factor VII and rescue liver transplantation. Minerva Anestesiol
http://www.ncbi.nlm.nih.gov/pubmed/20386514
D'Alleyrand JC, Dutton RP, and Pollak AN (2010) Extrapolation of battlefield resuscitative care to the civilian setting. J Surg Orthop Adv 19:62-69.
http://www.ncbi.nlm.nih.gov/pubmed/20371009
Girolami A, Scandellari R, and Lombardi AM (2010) The use of tissue thromboplastins of different origin is a fundamental tool in the initial characterization of FVII defects on "Factor VII Deficiency (Semin Thromb Hemost 2009;35(4):400-406)". Semin Thromb Hemost 36:123-124.
http://www.ncbi.nlm.nih.gov/pubmed/20391303
Johansen PB, Bjorn SE, Agerso H, Thorup I, Hermit MB, Sorensen B, Stennicke HR, Ezban M, and Tranholm M (2010) Prolonged effect of GlycoPEGylated rFVIIa (40k-PEG-rFVIIa) in rabbits correlates to activity in plasma. Thromb Haemost 104:
http://www.ncbi.nlm.nih.gov/pubmed/20390231
Larsen KS, Ostergaard H, Olsen OH, Bjelke JR, Ruf W, and Petersen LC (2010) Engineering of substrate selectivity for tissue factor-factor VIIa complex signaling through protease activated receptor 2. J Biol Chem
http://www.ncbi.nlm.nih.gov/pubmed/20388709
Maraveyas A, Ettelaie C, Echrish H, Li C, Gardiner E, Greenman J, and Madden LA (2010) Weight-adjusted dalteparin for prevention of vascular thromboembolism in advanced pancreatic cancer patients decreases serum tissue factor and serum-mediated induction of cancer cell invasion. Blood Coagul Fibrinolysis
http://www.ncbi.nlm.nih.gov/pubmed/20386431
Neeves KB, Illing DA, and Diamond SL (2010) Thrombin flux and wall shear rate regulate fibrin fiber deposition state during polymerization under flow. Biophys J 98:1344-1352.
http://www.ncbi.nlm.nih.gov/pubmed/20371335
Nishijima DK, Dager WE, Schrot RJ, and Holmes JF (2010) The efficacy of factor VIIa in emergency department patients with warfarin use and traumatic intracranial hemorrhage. Acad Emerg Med 17:244-251.
http://www.ncbi.nlm.nih.gov/pubmed/20370756
Piazza F, Galimberti G, Conti E, Isella V, Perlangeli MV, Speranza T, Borroni B, Pogliani EM, Padovani A, and Ferrarese C (2010) Increased tissue factor pathway inhibitor and homocysteine in Alzheimer's disease. Neurobiol Aging
http://www.ncbi.nlm.nih.gov/pubmed/20359777
Puddu P, Puddu GM, Cravero E, Muscari S, and Muscari A (2010) The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases. Can J Cardiol 26:140-145.
http://www.ncbi.nlm.nih.gov/pubmed/20386775
Skolnick BE, Mathews DR, Khutoryansky NM, Pusateri AE, and Carr ME (2010) Exploratory study on the reversal of warfarin with rFVIIa in healthy subjects. Blood
http://www.ncbi.nlm.nih.gov/pubmed/20385794
Sobti RC, Maithil N, Thakur H, Sharma Y, and Talwar KK (2010) Association of ACE and FACTOR VII gene variability with the risk of coronary heart disease in north Indian population. Mol Cell Biochem
http://www.ncbi.nlm.nih.gov/pubmed/20364300
Yamamoto T, Mita A, Ricordi C, Messinger S, Miki A, et al. (2010) Prolactin supplementation to culture medium improves beta-cell survival. Transplantation
http://www.ncbi.nlm.nih.gov/pubmed/20357700
________________________________________________
ABOUT TRIGGER
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
